Susanna Gatti High Dyne Therapeutics, Inc. (DYN) insider trading activity

Susanna Gatti High is Chief Operating Officer of Dyne Therapeutics, Inc.. Currently has a direct ownership of 154,062 shares of DYN, which is worth approximately $4.91 Million. The most recent transaction as insider was on May 16, 2024, when has been sold 2,738 shares (Common Stock) at a price of $28.4 per share, resulting in proceeds of $77,759. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 154K

18.0% 3M change

39.45% 12M change

Total Value Held $4.91 Million

SUSANNA GATTI HIGH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 16 2024	SELL Open market or private sale	$77,759 $28.4 p/Share	2,738 Reduced 1.75%	154,062 Common Stock
Mar 11 2024	SELL Open market or private sale	$58,904 $25.7 p/Share	2,292 Reduced 1.44%	156,800 Common Stock
Mar 08 2024	SELL Open market or private sale	$735,460 $27.04 p/Share	27,199 Reduced 14.6%	159,092 Common Stock
Mar 07 2024	SELL Open market or private sale	$41,127 $25.85 p/Share	1,591 Reduced 0.85%	186,291 Common Stock
Dec 11 2023	SELL Open market or private sale	$17,323 $10.72 p/Share	1,616 Reduced 0.85%	187,882 Common Stock
Nov 15 2023	BUY Grant, award, or other acquisition	-	94,893 Added 33.37%	189,498 Common Stock
Nov 02 2023	SELL Open market or private sale	$73,548 $7.4 p/Share	9,939 Reduced 9.51%	94,605 Common Stock

Sep 18 2023	SELL Open market or private sale	$25,143 $9.41 p/Share	2,672 Reduced 2.49%	104,544 Common Stock
Sep 12 2023	SELL Open market or private sale	$17,020 $10.41 p/Share	1,635 Reduced 1.5%	107,216 Common Stock
Jun 13 2023	SELL Open market or private sale	$20,198 $12.43 p/Share	1,625 Reduced 1.47%	108,851 Common Stock
Mar 14 2023	SELL Open market or private sale	$20,781 $13.33 p/Share	1,559 Reduced 1.39%	110,476 Common Stock
Dec 12 2022	SELL Open market or private sale	$8,163 $10.87 p/Share	751 Reduced 0.67%	112,035 Common Stock
Dec 09 2022	BUY Grant, award, or other acquisition	-	44,000 Added 28.06%	112,786 Common Stock
Sep 20 2022	SELL Sale (or disposition) back to the issuer	$36,017 $13.7 p/Share	2,629 Reduced 3.68%	68,786 Common Stock
Sep 15 2022	SELL Sale (or disposition) back to the issuer	$11,043 $14.05 p/Share	786 Reduced 1.09%	71,415 Common Stock
Jun 14 2022	SELL Sale (or disposition) back to the issuer	$3,970 $4.95 p/Share	802 Reduced 1.1%	72,201 Common Stock
Mar 11 2022	SELL Open market or private sale	$6,678 $8.73 p/Share	765 Reduced 1.04%	73,003 Common Stock
Dec 10 2021	BUY Grant, award, or other acquisition	-	40,315 Added 35.34%	73,768 Common Stock
Sep 23 2021	SELL Open market or private sale	$42,206 $17.22 p/Share	2,451 Reduced 6.83%	33,453 Common Stock

SGH

Susanna Gatti High

Chief Operating Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DYN shares.

Notify only if

Value

Insider Trading

Get notified when an Dyne Therapeutics, Inc. insider buys or sells DYN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Dyne Therapeutics, Inc.

Track Activities on DYN

Account